Efficacy and Safety of Etrolizumab in the Treatment of Moderate to Severe Ulcerative Colitis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Jaber F., Department of Medicine, University of Missouri-Kansas City, Kansas City, MO, United States; Alsakarneh S., Department of Medicine, University of Missouri-Kansas City, Kansas City, MO, United States, Faculty of Medicine, Al-Quds University, Jerusalem, Palestine; Ayyad M., Faculty of Medicine, Al-Quds University, Jerusalem, Palestine; Alsharaeh T., Department of Medicine, The University of Jordan, Faculty of Medicine, Amman, Jordan; Salahat A.-J., Department of Medicine, The University of Jordan, Faculty of Medicine, Amman, Jordan; Jaber M., Department of Medicine, Al-Azhar University, Faculty of Medicine, Gaza, Palestine; Kilani Y., Department of Internal Medicine, NYC Health + Hospitals, Lincoln - Weill Cornell Medical College, Bronx, NY, United States; Aldiabat M., Department of Epidemiology, Harvard School of Public Health, Boston, MA, United States, Department of Internal Medicine, Washington University in St. Louis, St. Louis, MO, United States; Gangwani M.K., Department of Internal Medicine, University of Toledo, Toledo, OH, United States; Abboud Y., Department of Internal Medicine, Rutgers New Jersey Medical School, Newark, NJ, United States; Fares A., Department of Medicine, Tufts Medical Center, Boston, MA, United States; Dahiya D.S., Division of Gastroenterology Hepatology & Motility, The University of Kansas School of Medicine, Kansas City, KS, United States; Ahmed M., Division of Gastroenterology, University of Missouri-Kansas City, Kansas City, MO, United States; Shukla R., Department of Medicine, Section of Gasteroenterology and Hepatology, Baylor College of Medicine, Houston, TX, United States